ArticleFrontiers in immunology2025

Cost-effectiveness of cadonilimab plus chemotherapy vs chemotherapy alone for advanced gastric cancer: evidence to inform drug pricing in the U.S. and China.

Wenwang Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.